TerrAscend Corp.

TSX:TSND.TO

Drug Manufacturers - Specialty & Generic

Healthcare
$0.52 -1.61%

-$0.02 today

Market cap
$193.65M
Beta
2.04
P/E (TTM)
-2.5
EPS (TTM)
-$0.26
52W Low $0.33High $2.00

Volume 0.26M

Average 0.31M

TSND.TO Net Receivables

Amounts owed to the company by customers and others, net of allowances for uncollectible accounts.

TerrAscend Corp.TSX: TSND.TO

Net Receivables · Q1 FY2026 · quarter ended Mar 2026

Net receivables falls 17.1% from a year ago

Net receivables stood at $15.56M at the end of Q1 FY2026, down 17.1% from a year earlier and down 7.8% from the prior quarter. Over 3 fiscal years it compounded at -9.4% a year.

Context

  • Net receivables amounted to 2.8% of total assets at the end of Q1 FY2026, down 0.3 pp from a year earlier.
  • Net receivables increased in 1 of the last 3 fiscal years.
  • FY2025 was the lowest annual figure in the 4 fiscal years shown.

What to watch

Whether net receivables keeps falling in the next quarterly balance sheet after a -17.1% change from a year earlier.

Sources:Balance SheetText generated from reported figures; not investment advice.

Latest quarterMar 2026
$15.56M-7.8% QoQ
Last fiscal yearDec 2025
$16.87M-37.9% YoY
Year agoMar 2025
$18.77M-17.1% since
Net Receivables past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter-17.1%——
1 year-37.9%——
3-year CAGR-9.4%——
5-year CAGR——
10-year CAGR——

Net Receivables history

USD · from the balance sheet

Latest · FY2025
16.87M USD
Year-over-year change
-37.9%
4-year CAGR
+8.0%

Net Receivables vs competitors

How TSND.TO compares with its peers on the latest reported figures

  • Peers report in different currencies, so net receivables is compared through growth and share of total assets rather than absolute size.
  • Its year-over-year change of -17.1% is the 7th highest of 10, against a peer median of +5.0%.
  • Net receivables amounts to 2.8% of total assets for TSND.TO, versus a peer median of 7.4%.
TSND.TO Competitors
Net Receivables for TSND.TO and competitors
Company Period Latest balance YoY 3-year CAGR% of assets
OGI.TOOrganiGram Holdings Inc.Mar 2026CA$53.39M CAD+6.8%—10.2%
ACB.TOAurora Cannabis Inc.Mar 2026CA$44.58M CAD+5.0%+2.5%7.4%
WEED.TOCanopy Growth CorporationMar 2026CA$36.29M CAD-31.2%-19.1%3.2%
DR.TOMedical Facilities CorporationMar 2026$33.17M USD-24.8%-18.3%11.9%
XLY.TOAuxly Cannabis Group Inc.Mar 2026CA$21.12M CAD-6.5%+8.5%7.6%
FRX.TOFennec Pharmaceuticals Inc.Mar 2026$18.71M USD+21.1%+146.6%26.1%
TSND.TOTerrAscend Corp.Mar 2026$15.56M USD-17.1%-9.4%2.8%
CPH.TOCipher Pharmaceuticals Inc.Mar 2026$9.76M USD-17.1%+18.0%6.4%
HLS.TOHLS Therapeutics Inc.Mar 2026$8.14M USD+16.6%-11.2%6.2%
EPRX.TOEupraxia Pharmaceuticals Inc.Mar 2026$663.7K USD+178.2%+76.9%0.5%
Peer median (excluding TSND.TO) —+5.0%+5.5%7.4%

Competitors are the stored peer set for TSND.TO. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Balance Sheet

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Cash & Equivalents100.55M36.31M22.24M26.38M37.46M
Short-term Investments03.63M1.91M1.73M361.34K
Net Receivables12.38M22.66M19.05M27.15M16.87M
Inventory35.79M46.75M51.68M48.8M33.99M
Other Current Assets38.88M7.55M8M373.79K21.23M
Total Current Assets171.05M123.1M102.89M104.43M109.91M
Property, Plant & Equipment (Net)178.79M332.78M239.66M324.13M156.34M
Goodwill89.57M91.15M106.93M153.73M109.57M
Intangible Assets167.02M241.88M215.85M243.84M167.01M
Long-term Investments68.05M0609.48K00
Tax Assets5.01M0(609.48K)19.21M10.47M
Other Non-current Assets8.47M120.6M1.19M(238.26M)13.54M
Total Non-current Assets516.92M786.41M563.63M502.8M456.93M
Total Assets734.69M951.93M666.52M607.23M566.83M
Account Payables27.69M44.35M49.9M46.73M37.57M
Short-term Debt8.26M52.02M137.74M6.76M17.16M
Tax Payables12.15M31.31M6.3M11.53M0
Deferred Revenue1.35M3.98M4.15M5.13M3.99M
Other Current Liabilities13.49M7.55M717K887K14.21M
Total Current Liabilities65.64M139.15M207M78.53M79.79M
Long-term Debt169.74M147.17M68.9M192.58M210.36M
Deferred Tax Liabilities14.27M59.6M17.18M8.43M18.48M
Deferred Revenue (Non-current)067.1M000
Other Non-current Liabilities84.17M3.31M104.09M107.7M130.87M
Total Non-current Liabilities284.41M329.04M218.78M351.89M388.21M
Total Liabilities445.64M516.16M425.78M430.41M467.99M
Common Stock00000
Retained Earnings(312.03M)(623.86M)(928.51M)(778.51M)(863.17M)
Accumulated OCI2.8M2.1M1.8M3.01M1.98M
Other Stockholders Equity00573.16K00
Minority Interest6.78M3.22M(2.33M)(207.1K)1.53M
Total Equity289.05M435.77M240.74M176.82M98.84M
Total Debt209.67M248.25M255.7M246.18M256.49M
Net Debt166.39M298.58M233.46M219.8M219.03M

TerrAscend Corp.

TSX:TSND.TO

Intrinsic Alpha fair value

Locked

Current Price

$0.52

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.